Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease — Hannes Alber (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease
Shared by
Jozef Dulak
Jagiellonian University Cracow
Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease
Article
2002
en
Authors
+4 more
HA
Hannes Alber
Jozef Dulak
Jagiellonian University Cracow
MF
Matthias Frick
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2000
Atorvastatin therapy reduces vascular endothelial growth factor (VEGF) in patients with coronary artery disease
Hannes Alber
,
Jozef Dulak
,
Severin P. Schwarzacher
,
Otmar Pachinger
,
Franz Weidinger
Article
2024
Endothelial dysfunction and coronary artery disease in patients with COPD
Mairi Macleod
,
Kristopher Knott
,
Ralph Lopez
,
Sam Bartlett‐Pestell
,
Aaron Braddy-Green
,
Ramzi Khamis
,
Peter J Barnes
,
Peter Collins
,
Ed D Nicol
,
Jadwiga A. Wedzicha
,
Koralia Paschalaki
Article
1999
Role of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptors in Vascular Development
Peter Carmeliet
,
Désiré Collen
Article
1994
Vascular Remodeling in Coronary Artery Disease
Carlo Di Mario
,
Peter Ruygrok
,
Patrick W. Serruys
Journal of Cardiovascular Pharmacology
Article
1994
Vascular Remodeling in Coronary Artery Disease
Carlo Di Mario
,
Peter Ruygrok
,
Patrick W. Serruys
Journal of Cardiovascular Pharmacology
.webp)
Discussion(0)
No comments yet. Be the first to comment.